Gene expression profiling predicts clinical outcome of prostate cancer
Open Access
- 15 March 2004
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 113 (6) , 913-923
Abstract
One of the major problems in management of prostate cancer is the lack of reliable genetic markers predicting the clinical course of the disease. We analyzed expression profiles of 12,625 transcripts in prostate tumors from patients with distinct clinical outcomes after therapy as well as metastatic human prostate cancer xenografts in nude mice. We identified small clusters of genes discriminating recurrent versus nonrecurrent disease with 90% and 75% accuracy in two independent cohorts of patients. We examined one group of samples (21 tumors) to discover the recurrence predictor genes and then validated the predictive power of these genes in a different set (79 tumors). Kaplan-Meier analysis demonstrated that recurrence predictor signatures are highly informative (P < 0.0001) in stratification of patients into subgroups with distinct relapse-free survival after therapy. A gene expression–based recurrence predictor algorithm was informative in predicting the outcome in patients with early-stage disease, with either high or low preoperative prostate-specific antigen levels and provided additional value to the outcome prediction based on Gleason sum or multiparameter nomogram. Overall, 88% of patients with recurrence of prostate cancer within 1 year after therapy were correctly classified into the poor-prognosis group. The identified algorithm provides additional predictive value over conventional markers of outcome and appears suitable for stratification of prostate cancer patients at the time of diagnosis into subgroups with distinct survival probability after therapy.Keywords
This publication has 23 references indexed in Scilit:
- Microarray analysis of xenograft‐derived cancer cell lines representing multiple experimental models of human prostate cancerMolecular Carcinogenesis, 2003
- A role for Wnt signalling in self-renewal of haematopoietic stem cellsNature, 2003
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysisThe Prostate, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- MOLECULAR GENETIC PROFILING OF GLEASON GRADE 4/5 PROSTATE CANCERS COMPARED TO BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2001
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001